Lantern Pharma Secures Major Year-Long National Media Partnership
Lantern Pharma, an AI-driven oncology company advancing multiple clinical-stage cancer therapies, will gain significant national visibility through a new, year-long media partnership with New to The Street, one of America’s leading business television and multi-platform media brands. Through this partnership, Lantern Pharma will be featured prominently across national TV interviews, commercial campaigns, earned media placements, and high-impact billboard displays throughout New York City’s Financial District and Times Square. The collaboration also includes non-deal roadshow coverage, bringing Lantern’s scientific and clinical progress directly to institutional and accredited investors across key U.S. markets. Lantern will appear across New to The Street’s nationally syndicated broadcasts on Bloomberg Television and Fox Business Network, supported by robust digital, social, and outdoor media exposure—expanding the company’s reach as it advances its AI-enabled cancer drug development programs.
Lantern Pharma Secures Major Year-Long National Media Partnership